Sarcoma

After being diagnosed with cancer, I took a hard look at what I was eating and made some positive changes.

After cancer, I now have more empathy for people going through health crises, though when I see others posting inspirational stories on social media, I can’t help but to wonder how much strife they have actually been through.

Adolescents and young adults with sarcoma, a group of cancers that begin in the bone and soft tissue, need more education regarding chronic pain management and opioid addiction, according to a group of researchers.

Seeing a friend meet up for a business meeting made me miss my fast-paced life before cancer, but reminded me to trust the process of where I am now.

The use of the chemotherapy ifosfamide was associated with small improvements in survival outcomes in a group of patients with relapsed/refractory Ewing sarcoma, a rare type of bone or soft tissue cancer.

I trusted my oncology team with my life, so it was important that I found doctors I was comfortable with.

From chef Gordon Ramsay sharing a meal with a 13-year-old fan with Ewing sarcoma, to a dermatologist on a playground spotting a mother’s skin cancer, here’s a look at what’s happening in the cancer space this week.

I didn’t know that starting a blog and turning to social media at the age of 30 after a cancer diagnosis would be so beneficial. But, I’m glad it turned out that way.

The cancer experience is far from over when scans turn up clear. Here’s how I deal with triggering reminders of the disease.

The first patient was dosed in a clinical trial evaluating the radiopharmaceutical agent, CycloSam, in patients with bone cancer or cancer that has metastasized to the bone.

Throughout my cancer experience, I’ve relied heavily on friends and family for support. But as they are moving on and starting families of their own, I realized how much time I’ve lost to cancer.

From an osteosarcoma survivor modeling inclusivity in the fashion world to rock guitarist Paul “Bonehead” Arthurs being diagnosed with cancer, here’s what’s happening in the cancer space this week.

My wife and I took a weekend break from the worries of cancer and everyday life, but things did not go as planned, forcing me to tap into all the self-work I’ve been focusing on this year.

From liver cancer survivor planning to run the upcoming Boston Marathon with his organ donor to a common HIV drug showing promise in treating colorectal cancer, here’s what’s happening in the cancer space this week.

Aesthetic appearances, according to an expert at the UCSF, are often important for patients following the surgical treatment of cancer. Advancements in this space over the past 20 years have allowed many to patients to look as normal as possible.

My osteosarcoma has been under control for a few years now, and in my moments of free time, I start to feel guilty for lacking the drive to take on more.

Significant challenges include improving detection and response to inner ear side effects among cancer survivors following the use of certain drugs and therapies.

The post-scanxiety crash felt like an avalanche for me, and even though my scans were clear, it took talking to another cancer survivor to snap me out of it.

Children with low skeletal muscle density were more likely to have hematologic toxicities from chemotherapy, but more research is needed to determine whether this measure is an accurate predictor of chemotoxicities in lymphoma.

This marks the only available treatment option approved by the FDA for adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.

The first patient has been enrolled in the APOLLO 613 Phase 1/2 clinical trial for CPI-613.

A phase 3 clinical trial has begun to evaluate the efficacy and safety of milademetan in patients with de-differentiated liposarcoma.

A survivor of myxofibrosarcoma expresses his thoughts about cancer recurrence and treatment options in a poem.

Liposarcoma survivor Arianne Missimer discusses the training process for ‘American Ninja Warrior’ and how she felt the day of competition.

Despite the challenges of diagnosing and treating liposarcoma and chondrosarcoma, experts are optimistic about future treatments for these two rare cancers.